AIDS - Related Kaposi's Sarcoma – Pipeline Review, H2 2012

Published : July 2012
No. of Pages : 51

Price:

AIDS - Related Kaposi''s Sarcoma – Pipeline Review, H2 2012

Summary

Global Markets Direct’s, ''AIDS - Related Kaposi''s Sarcoma - Pipeline Review, H2 2012'', provides an overview of the AIDS - Related Kaposi''s Sarcoma therapeutic pipeline. This report provides information on the therapeutic development for AIDS - Related Kaposi''s Sarcoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for AIDS - Related Kaposi''s Sarcoma. ''AIDS - Related Kaposi''s Sarcoma - Pipeline Review, H2 2012'' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for AIDS - Related Kaposi''s Sarcoma.
- A review of the AIDS - Related Kaposi''s Sarcoma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the AIDS - Related Kaposi''s Sarcoma pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for AIDS - Related Kaposi''s Sarcoma.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding AIDS - Related Kaposi''s Sarcoma pipeline depth and focus of AIDS - Related Kaposi''s Sarcoma therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
AIDS - Related Kaposi''s Sarcoma Overview 7
Therapeutics Development 8
An Overview of Pipeline Products for AIDS - Related Kaposi''s Sarcoma 8
AIDS - Related Kaposi''s Sarcoma Therapeutics under Development by Companies 10
AIDS - Related Kaposi''s Sarcoma Therapeutics under Investigation by Universities/Institutes 11
Mid Clinical Stage Products 13
Comparative Analysis 13
Early Clinical Stage Products 14
Comparative Analysis 14
Pre-Clinical Stage Products 15
Comparative Analysis 15
AIDS - Related Kaposi''s Sarcoma Therapeutics – Products under Development by Companies 16
AIDS - Related Kaposi''s Sarcoma Therapeutics – Products under Investigation by Universities/Institutes 17
Companies Involved in AIDS - Related Kaposi''s Sarcoma Therapeutics Development 18
Aphios Corporation 18
Azaya Therapeutics, Inc. 19
PTC Therapeutics, Inc. 20
Arisyn Therapeutics Inc. 21
AIDS - Related Kaposi''s Sarcoma – Therapeutics Assessment 22
Assessment by Monotherapy Products 22
Assessment by Combination Products 23
Assessment by Route of Administration 24
Assessment by Molecule Type 26
Drug Profiles 28
Dermos - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
PTC299 - Drug Profile 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
ATI 0607 - Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
Rapamycin - Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Bevacizumab - Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
Gleevec - Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
SU5416 - Drug Profile 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
Bortezomib - Drug Profile 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
Lenalidomide - Drug Profile 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
Halofuginone Hydrobromide - Drug Profile 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
Interferon beta-1b + Zidovudine - Drug Profile 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
Lenalidomide - Drug Profile 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
HAART + Bevacizumab - Drug Profile 41
Product Description 41
Mechanism of Action 41
R&D Progress 42
ATI-0918 - Drug Profile 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
AIDS - Related Kaposi''s Sarcoma Therapeutics – Drug Profile Updates 44
AIDS - Related Kaposi''s Sarcoma Therapeutics - Dormant Products 45
AIDS - Related Kaposi''s Sarcoma – Product Development Milestones 49
Featured News & Press Releases 49
Aug 05, 1997: Taxol Approved for Kaposi''s Sarcoma 49
Appendix 50
Methodology 50
Coverage 50
Secondary Research 50
Primary Research 50
Expert Panel Validation 50
Contact Us 51
Disclaimer 51

List of Tables
Number of Products Under Development for AIDS - Related Kaposi''s Sarcoma, H2 2012 8
Products under Development for AIDS - Related Kaposi''s Sarcoma – Comparative Analysis, H2 2012 9
Number of Products under Development by Companies, H2 2012 10
Number of Products under Investigation by Universities/Institutes, H2 2012 12
Comparative Analysis by Mid Clinical Stage Development, H2 2012 13
Comparative Analysis by Early Clinical Stage Development, H2 2012 14
Comparative Analysis by Pre-Clinical Stage Development, H2 2012 15
Products under Development by Companies, H2 2012 16
Products under Investigation by Universities/Institutes, H2 2012 17
Aphios Corporation, H2 2012 18
Azaya Therapeutics, Inc., H2 2012 19
PTC Therapeutics, Inc., H2 2012 20
Arisyn Therapeutics Inc., H2 2012 21
Assessment by Monotherapy Products, H2 2012 22
Assessment by Combination Products, H2 2012 23
Assessment by Stage and Route of Administration, H2 2012 25
Assessment by Stage and Molecule Type, H2 2012 27
AIDS - Related Kaposi''s Sarcoma Therapeutics – Drug Profile Updates 44
AIDS - Related Kaposi''s Sarcoma Therapeutics – Dormant Products 45
AIDS - Related Kaposi''s Sarcoma Therapeutics – Dormant Products (Contd..1) 46
AIDS - Related Kaposi''s Sarcoma Therapeutics – Dormant Products (Contd..2) 47
AIDS - Related Kaposi''s Sarcoma Therapeutics – Dormant Products (Contd..3) 48

List of Figures
Number of Products under Development for AIDS - Related Kaposi''s Sarcoma, H2 2012 8
Products under Development for AIDS - Related Kaposi''s Sarcoma – Comparative Analysis, H2 2012 9
Products under Development by Companies, H2 2012 10
Products under Investigation by Universities/Institutes, H2 2012 11
Mid Clinical Stage Products, H2 2012 13
Early Clinical Stage Products, H2 2012 14
Pre-Clinical Stage Products, H2 2012 15
Assessment by Monotherapy Products, H2 2012 22
Assessment by Combination Products, H2 2012 23
Assessment by Route of Administration, H2 2012 24
Assessment by Stage and Route of Administration, H2 2012 25
Assessment by Molecule Type, H2 2012 26
Assessment by Stage and Molecule Type, H2 2012 27

AIDS - Related Kaposi's Sarcoma – Pipeline Review, H2 2012

Published By: Global Markets Direct

Price:

How to Purchase

Purchase products from our site in 5 easy steps. Please follow the description given below to complete your purchase process.

Step 1:

Select the report title of your interest, and Click on Buy Now button next to the Price option.

Step 2:

You will arrive at the Purchase page, where you will be requested to Signup (New User) or Login (Registered User). Please note that in-keeping with the security check on the website, you must submit your full details to avoid any inconvenience arising from incorrectly entered data or counterfeit information.

Step 3:

After SignUp/Login, you will arrive at the Online Invoice Page. Select a Payment option via various methods: Debit Card / Credit Card / by Invoice. MarketReportOnline accepts Visa, MasterCard, American Express and all major credit cards. MarketReportOnline uses ICICI, HDFC, Citibank, American Express & Paypal as our Online Payment Gateway Partners. Clicking on a payment option will take you to the corresponding Payment Gateway page.

Step 4:

Once at the Payment Gateway, please complete the Payment Process to purchase your desired report.

Step 5:

Once you have successfully completed the purchase process, you will receive a confirmation email. You will then either be able to download your report immediately (in PDF Format) from the Account Login button, or the report will be emailed to you directly, depending upon the agreement we have with the publisher. For Orders that are deliverable via email and placed after working hours, the delivery of the reports will be made on the next business day. Please note, if you select purchase by invoice, you will receive your report only once the payment has been received. If you have any queries about how to order, please Contact Us .

sales@marketreportsonline.com + 1 888 391 5441

Using our subscription option, you get access to market research reports and industry data of Industry Profiles market as per your needs. Get the best of Industry Profiles research reports by utilizing your research budgets in an optimum way.
More about our Subscription option

Get Email alerts about market research reports from industries and publishers of your interest: